TECC-T1D3 Program: The TECC-T1D3 program is a twelve-week virtual care intervention designed to support individuals with Type 1 Diabetes (T1D) and Diabetes Distress. The program includes a health coach (HC) and a virtual care team (VCT) of T1D, mental health experts and peer support, offering comprehensive care through various communication channels, including WebEx, phone calls, and text messaging. The program aims to: i. Provide T1D specific mental health and wellbeing support, ii. Provide guidance on how to communicate with others about T1D, manage stigma and ask for help with diabetes management and iii. Facilitate connections with T1D communities. Participants can choose topics of discussion based on their needs and will be directly supported by the HC and indirectly monitored by VCT.
Education Intervention: The Education Intervention is a low-intensity, education-focused intervention consisting of 10 automated emails over 12 weeks, providing generalized educational messages with links to resources for mental health support and well-being for individuals living with T1D.
Study summary
The goal of the study is to evaluate the acceptability and feasibility of a co-designed, Technology-Enabled Collaborative Care for Young Adults with Type-1 Diabetes and Diabetes Distress (TECC-T1D3) program. Through this program, the investigators aim to deliver a collaborative care intervention, featuring a health coach and a virtual care team, designed to help participants manage mental health and overall wellbeing.
Eligibility
Sex
ALL
Min age
18 Years
Max age
29 Years
Healthy volunteers
No
Inclusion Criteria:
* Young adult (age 18-29 years)
* Resident of Ontario
* Living with a self-reported diagnosis of T1D of at least 1 year
* Individual is community-living (people who live independently in the community and are not residing in a setting that provide institutional care or support)
Exclusion Criteria:
* Unable to participate in English language
* Unable to participate via telephone or web-conferencing
Primary outcome measure(s)
Feasibility - Recruitment Rate (Both Arms) — Through the study completion, an average of 6 months The primary outcome in this study is feasibility specifically focusing on process outcomes. This includes assessing recruitment number.
Feasibility - Engagement Rate (Both Arms) — From consent to randomization throughout the study (average of 6 months) The primary outcome in this study is feasibility, specifically focusing on process outcomes. This includes percentage of consented participants who proceed to randomization.
Feasibility - Completion of Study Assessments (Both Arms) — Up to 12-weeks Coaching Intervention: Participants attending a minimum of 8 sessions out of a possible maximum of 10 sessions Education Intervention: Participants opening a minimum of 8 emails out of the 10 emails
Acceptability - Qualitative (Both Arms) — Within two weeks post-intervention, after completing the 12-weeks program Participants' perceptions, experiences, and satisfaction with the intervention assessed through post-intervention interviews. Interviews will explore perceived impact on health, motivation, and suggestions for improvement.
Delivery of the Digital Intervention - Number of Sessions Completed (Coaching Intervention only) — Up to 12-weeks • The number of sessions completed.
Delivery of the Digital Intervention - Mode of Interaction (Coaching Intervention only) — Up to 12-weeks Measurement include:
• Number of interaction categorized by the mode of delivery (web-conference, telephone or text message).
Delivery of Digital Intervention - Time Spent per Session (Coaching Intervention only) — Up to 12-weeks • Average time spent by health coach per interaction/session with participants in minutes.
Trial sites (1)
Facility
City
Region
Status
Centre for Addiction and Mental Health
Toronto
Ontario
Recruiting
More Centre for Addiction and Mental Health trials in Canada
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.